Evidence map›Paper›PMID 39976715›Full record

ArticleZeitschrift fur Rheumatologie2025

[Pregnancy and lactation-associated osteoporosis: risk factors and treatment].

Katja Warnecke, Burkhard Muche, Andreas Krause, Paula Hoff

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Zeitschrift fur Rheumatologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Bioactives in Food-As-Medicine for Special Medical Purposes.Advances in nutrition (Bethesda, Md.) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Katja WarneckeFachabteilung für Innere Medizin - Rheumatologie, Klinische Immunologie und Osteologie, Immanuel-Krankenhaus Berlin-Wannsee, Berlin, Deutschland.
Burkhard MucheMed. Klinik mit Schwerpunkt Rheumatologie und klinische Immunologie und Interdisziplinäres Zentrum für Osteologie der Charité, Charité Universitätsmedizin Berlin (Campus Mitte), Berlin, Deutschland.
Andreas KrauseFachabteilung für Innere Medizin - Rheumatologie, Klinische Immunologie und Osteologie, Immanuel-Krankenhaus Berlin-Wannsee, Berlin, Deutschland.
Paula HoffMed. Klinik mit Schwerpunkt Rheumatologie und klinische Immunologie und Interdisziplinäres Zentrum für Osteologie der Charité, Charité Universitätsmedizin Berlin (Campus Mitte), Berlin, Deutschland. paula.hoff@amedes-group.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pregnancy and lactation-associated osteoporosis (PLO) is a rare but serious condition. Multiple fractures often occur, mostly in the form of vertebral fractures, the mother is severely restricted and caring for the infant is barely possible without assistance. The fractures causing the complaints usually occur in the last trimester of the first pregnancy or in the first weeks of lactation. Magnetic resonance imaging (MRI) can be used to detect vertebral fractures and also edematous vertebrae. Bone densitometry is helpful for the diagnostics and assessment of progression. It is extremely important to distinguish PLO from other secondary forms of osteoporosis that can also be manifested during pregnancy and lactation. The mother is advised to stop breastfeeding immediately in order to interrupt calcium mobilization from bone and to achieve a normalization of hormone levels. Calcium and vitamin D should be supplemented and adequate pain treatment and physiotherapy should be initiated. The quality of data is poor due to the rarity of the disease, all available anti-osteoporotic drugs have been used in case reports but overall, in the last decade off-label treatment with teriparatide has been proven to be helpful and safe.

Indexed as

Bone Density Conservation AgentsBreast FeedingOsteoporosisOsteoporotic FracturesPregnancy ComplicationsFemaleHumansLactationPregnancyRisk FactorsTreatment OutcomeVitamin DBone Density Conservation AgentsVitamin DAnti-osteoporotic agentsBone densitometryFractures in pregnancy and lactationMagnetic resonance imagingTeriparatide

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.